Authors: GREIM G ESKENS F HOPPENER F BARBET NC CHOI L HANAUSKE AR VERWEIJ J BRUNTSCH U

Citation: G. Greim et al., PHASE-I TOLERABILITY - PHARMACOLOGICAL STUDY OF CGP48664, A NOVEL POLYAMINE BIOSYNTHESIS INHIBITOR, GIVEN IV ONCE WEEKLY X 4 (Q 6 WKS) TO PATIENTS WITH SOLID TUMORS, Annals of oncology, 9, 1998, pp. 443-443